Journal of Cutaneous and Aesthetic Surgery
Print this page
Email this page
Small font size
Default font size
Increase font size
Home About us Current issue Archives Instructions Submission Subscribe Editorial Board Partners Contact e-Alerts Login 

    Article Cited by others


Botulinum toxin deaths: What is the fact?

Omprakash H M, Rajendran S C

Year : 2008| Volume: 1| Issue : 2 | Page no: 95-97

   This article has been cited by
1 Adverse Events Associated With Botox as Reported in a Food and Drug Administration Database
Salma Ahsanuddin, Savannah Roy, Wissam Nasser, Roman Povolotskiy, Boris Paskhover
Aesthetic Plastic Surgery. 2021; 45(3): 1201
[Pubmed]  [Google Scholar] [DOI]
2 A Review of Tolerance and Safety Profiles of Long-Term Botulinum Neurotoxin Type A in Asian Patients with Hemifacial Spasm and Benign Essential Blepharospasm
Kenneth Ka Hei Lai, Alan Tsang, Andrew K. T. Kuk, Callie K. L. Ko, Edwin Chan, Simon T. C. Ko
Neuro-Ophthalmology. 2021; 45(5): 293
[Pubmed]  [Google Scholar] [DOI]
3 Perspectives for the use of therapeutic Botulinum toxin as a multifaceted candidate drug to attenuate COVID-19
Mahesh Kandasamy
Medicine in Drug Discovery. 2020; 6: 100042
[Pubmed]  [Google Scholar] [DOI]
4 New analgesic: Focus on botulinum toxin
Zdravko Lackovic
Toxicon. 2020; 179: 1
[Pubmed]  [Google Scholar] [DOI]
5 OnabotulinumtoxinA Injections for Patients with Chronic Migraine During the COVID-19 Pandemic
Samer Narouze
Annals Of Headache Medicine Journal. 2020;
[Pubmed]  [Google Scholar] [DOI]
6 Case of iatrogenic botulism after botulinotherapy in clinical practice
R A Ibatullin, R V Magjanov
Terapevticheskii arkhiv. 2018; 90(11): 102
[Pubmed]  [Google Scholar] [DOI]
7 Iatrogenic Botulism After Botulinum Toxin Type A Injections :
Arzu Coban, Zeliha Matur, Hasmet A. Hanagasi, Yesim Parman
Clinical Neuropharmacology. 2010; 33(3): 158
[HTML Full text]  [Google Scholar] [DOI]


Read this article